Clinical Trial

Ultrahypofractionated Whole Breast Radiation Following Chemotherapy

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a single institution, non-randomized, non-inferiority study comparing prospectively collected data for acute and late effects on the breast associated with ultrahypofractionated whole breast radiation (WBI) following breast conserving surgery (BCS) and chemotherapy to historical controls for breast cancer (BC) patients who receive hypofractionated RT following BCS and chemotherapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-28; most recent amendment 2025-03-13.
Trial Details
NCT Number NCT06664892
Lead Sponsor MetroHealth Medical Center
Conditions Breast Cancer
Enrollment 213 participants
Start Date 2025-04-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-14